Anti-D donors recognized in Holguín
- Written by Lourdes Pichs Rodríguez
- Category: Health
- Hits: 183
Cuban President Miguel Díaz-Canel praised the HEBERSaVax vaccine candidate, a unique therapeutic immunotherapy designed to treat various malignant tumors. Developed in Cuba, the product has shown promising results in Phase II clinical trials, offering hope for cancer patients with minimal side effects.